Metabolic syndrome among HIV infected patients: A comparative cross sectional study in northwestern Nigeria
Keywords: Metabolic syndrome; HIV; Northwestern Nigeria; HAART;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Impact of early versus deferred antiretroviral therapy on estimated glomerular filtration rate in HIV-positive individuals in the START trial
Keywords: HIV; Kidney; CKD; HAART; eGFR; START;
Liver Function Tests Abnormalities and Hepatitis B Virus & Hepatitis C Virus Co-infection in Human Immunodeficiency Virus (HIV)-infected Patients in India
Keywords: LFT abnormalities; HIV infection; viral hepatitis; HAART; ATT;
Oxygen binding isotope effects of triazole-based HIV-1 reverse transcriptase inhibitors indicate the actual binding site
Keywords: HIV-1 reverse transcriptase; Binding isotope effects; QM/MM; FEP; Free energy of binding; Interaction energy; Potential energy; NNRTIs; HAART; Triazole-based RTIs;
NK cells of HIV-1-infected patients with poor CD4+ T-cell reconstitution despite suppressive HAART show reduced IFN-γ production and high frequency of autoreactive CD56bright cells
Keywords: FMO; fluorescence minus one control; HAART; highly active antiretroviral therapy; HD; healthy donor; HIV; 1 human immunodeficiency virus type 1; IFN-γ; interferon-γ; LPS; lipopolysaccharides; mAb; mouse monoclonal antibody; MFI; Mean fluorescence intens
Comparative performances of serologic and molecular assays for detecting human T lymphotropic virus type 1 and type 2 (HTLV-1 and HTLV-2) in patients infected with human immunodeficiency virus type 1 (HIV-1)
Keywords: HTLV-1/2; HIV-1; Coinfection; Diagnosis; Immunoblotting; PCR; HAART;
Classical and alternative macrophages have impaired function during acute and chronic HIV-1 infection
Keywords: HIV-1; Innate immune response; HAART; Macrophages;
Impact of highly active antiretroviral therapy on the prevalence of oral lesions in HIV-positive patients: a systematic review and meta-analysis
Keywords: AIDS; HAART; HIV; human immunodeficiency virus; oral lesions;
Analysis of Retinochoroidal Vasculature in Human Immunodeficiency Virus Infection Using Spectral-Domain OCT Angiography
Keywords: AMD; age-related macular degeneration; FA; fluorescein angiography; FAZ; foveal avascular zone; HAART; highly active antiretroviral therapy; HIV; human immunodeficiency virus; OCTA; optical coherence tomography angiography; VFD; vessel flow density;
Comparative transcriptome analysis of PBMC from HIV patients pre- and post-antiretroviral therapy
Keywords: HIV; human immunodeficiency virus; AIDS; acquired immune deficiency syndrome; HAART; highly active antiretroviral therapy; PBMC; peripheral blood mononuclear cells; DEGs; differentially expressed genes; GSEA; Gene Set Enrichment Analysis; RIN; RNA integri
Prevalence of Peripheral Neuropathy and associated factors in HIV-infected patients
Keywords: PN; Peripheral Neuropathy; HAART; Highly Active Antiretroviral Therapy; MMSE; Mini-mental Status Exam; GCS; Glasgow Coma Scale; BPNS; Brief Peripheral Neuropathy Screening; HCV; Hepatitis C Virus; DSM-5; Diagnostic and Statistical Manual of Mental Disorde
UPLC-MS/MS method for the simultaneous quantification of three new antiretroviral drugs, dolutegravir, elvitegravir and rilpivirine, and other thirteen antiretroviral agents plus cobicistat and ritonavir boosters in human plasma
Keywords: Liquid chromatography; Tandem mass spectrometry; HAART; Reverse phase; Protein precipitation; Antiretrovirals;
HIV-associated cellular senescence: A contributor to accelerated aging
Keywords: Senescence; HIV; HAART; HIV-comorbidities; Premature aging; Substance abuse;
Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase
Keywords: Ocimum sanctum; HIV-1; RNase H; Reverse transcriptase; Triterpenes; Ferulic acid derivatives; AIDS; Acquired Immunodeficiency Syndrome; DCM; dichloromethane; DMAP; 4-dimethylaminopyridine; DP; DNA polymerase; DQF-COSY; Double Quantum Filtered-COrrelation
Azidothymidine-triphosphate impairs mitochondrial dynamics by disrupting the quality control system
Keywords: ATP; adenosine triphosphate; AZT; 3ê-azido-3ê-deoxythymidine; AZT-DP; AZT diphosphate; AZT-MP; AZT monophosphate; AZT-TP; AZT-triphosphate; calcein-AM; calcein acetoxymethyl ester; cDNA; complementary DNA; DHE; dihydroethidium; DMEM; Dulbecco's Modifi
Effects of antiretroviral treatment on paraoxonase 1 (PON1) activity in rats
Keywords: Paraoxonase; Antiretroviral therapy; Protease inhibitors; Dyslipidemia; Atherosclerosis; ART; Active Antiretroviral Therapy; ATV; atazanavir; HAART; Highly Active Antiretroviral Therapy; Hcy; homocysteine; HDL; High-density lipoprotein; HIV; Human Immunod
Nitric oxide levels in HIV-infected, untreated patients and HIV-infected patients receiving antiretroviral therapy
Keywords: HIV; HAART; Nitric oxide
The HIV-1 reverse transcriptase polymorphism A98S improves the response to tenofovir disoproxil fumarate + emtricitabine-containing HAART both in vivo and in vitro
Keywords: HIV-1; HAART; Reverse transcriptase; Virological success; Docking analysis;
Sennoside A, derived from the traditional chinese medicine plant Rheum L., is a new dual HIV-1 inhibitor effective on HIV-1 replication
Keywords: Sennoside A; HIV-1; Reverse transcriptase; Antiviral activity; Plant extracts; Dual inhibitor; DKA; diketo acid; EC50; HIV-1 replication by 50%; HAART; Highly Active Anti-Retroviral Therapy; HIV-1; Human Immunodeficiency Virus type 1; IN; integrase; INIs;
Hepatic histomorphological and biochemical changes following highly active antiretroviral therapy in an experimental animal model: Does Hypoxis hemerocallidea exacerbate hepatic injury?
Keywords: Liver morphology; HAART; Cytotoxicity; Stains; Biochemistry; Lipid profile;
Characterization of neuropathology in the HIV-1 transgenic rat at different ages
Keywords: ART; antiretroviral therapy; CC; corpus callosum; CSF; cerebrospinal fluid; CX; cortex; HAART; highly active antiretroviral therapy; HAD; HIV associated dementia; HAND; HIV-1 associated neurocognitive disorders; HC; hippocampus; IACUC; Institutional Anima
Insights into CYP2B6-mediated drug-drug interactions
Keywords: CAR; constitutive androstane receptor; C/EBP; CCAAT/enhancer-binding protein; CHOP; cyclophosphamide-doxorubicin-vincristine-prednisone; CITCO; (6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde-O-(3,4-dichlorobenzyl)oxime); COUP-TF; chic
2-hydroxyisoquinoline-1,3(2H,4H)-diones (HIDs) as human immunodeficiency virus type 1 integrase inhibitors: Influence of the alkylcarboxamide substitution of position 4
Keywords: HIV-1 integrase; Two-metal binding pharmacophore; Antiretroviral; 2-hydroxyisoquinoline-1,3(2H,4H)-diones; AZT; azidothymidine; CPE; cytopathic effect; CYP; cytochrome P450; FC; fold-change in EC50 relative to wild-type strain of HIV-1; FDA; food and drug
Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor
Keywords: Acm; acetamidomethyl; ACN; acetonitrile; Dbz; diaminobenzoyl; DHB; 2,5-dihydroxybenzoic acid; DIPEA; diisopropylethylamine; FP; fusion peptide; GBV-C; GB virus C; HAART; highly active antiretroviral therapy; HATU; 2-(1H-7-azabenzotriazole-1-yl)-1,1,3,3-te
Engineered nanoparticles of Efavirenz using methacrylate co-polymer (Eudragit-E100) and its biological effects in-vivo
Keywords: HIV; Human immunodeficiency virus; HAART; Highly active anti-retroviral therapy; AIDS; Acquired immunodeficiency virus syndrome; 3Tc; Lamivudine; FTC; Emtricitabine; BCS; Biopharmaceutical Classification System; CNS; Central nervous system; BBB; Blood Bra
HLA-DRB1454 and predictors of new-onset asthma in HIV-infected Thai children
Keywords: ART; antiretroviral therapy; HAART; highly active antiretroviral therapy; HLA; human leukocyte antigen; PREDICT; the Pediatric Randomized Early versus Deferred Initiation in Cambodia and Thailand study; Asthma; HIV-infected children; Antiretroviral therap
Efavirenz treatment causes arterial stiffening in apolipoprotein E-null mice
Keywords: HAART; Efavirenz; Atherosclerosis; Arterial stiffening; Vascular remodeling;
Altered brain functions in HIV positive patients free of HIV- associated neurocognitive disorders: A MRI study during unilateral hand movements
Keywords: HIV; fMRI; Motor cortex; Asymmetry; HAART
The effects of HAART on the expression of MUC1 and P65 in a cervical cancer cell line, HCS-2
Keywords: Cervical cancer; HAART; Cell death; MUC1; P65
Correlation between microstructure and bioequivalence in Anti-HIV Drug Efavirenz
Keywords: EFV; Efavirenz; HAART; High Activity Antiretroviral Therapy; WPPM; Whole Powder Pattern Modelling; UNAIDS; United Nations Program on HIV/AIDS; HIV-1; human immunodeficiency virus type 1; BCS; Biopharmaceutical Classification System; API; active pharmaceut
Immune Reconstitution Inflammatory Syndrome-Associated Burkitt Lymphoma After Combination Antiretroviral Therapy in HIV-Infected Patients
Keywords: Burkitt Lymphoma; HAART; HIV/AIDS; Immune Reconstitution Inflammatory Syndrome;
Prediction of brain atrophy using three drug scores in neuroasymptomatic HIV-infected patients with controlled viremia
Keywords: CPE; Monocyte efficacy score; Brain atrophy; HAART; HIV
Age, sex, and nutritional status modify the CD4+ T-cell recovery rate in HIV–tuberculosis co-infected patients on combination antiretroviral therapy
Keywords: HIV; Nutritional status; Immune-competence; Aging; HAART
The diffuse infiltrative lymphocytosis syndrome (DILS). A comprehensive review
Keywords: Diffuse infiltrative lymphocytosis syndrome; AIDS; HIV; CD8+ infiltration; HAART; Sicca signsDILS, diffuse infiltrative lymphocytosis syndrome; HAART, highly active anti-retroviral therapy; HIV, human immunodeficiency virus; AIDS, acquired immunodeficienc
Apport de l’étude des mécanismes de défense à une compréhension de la relation aux traitements antirétroviraux
Keywords: Approche compréhensive; Genre sexuel; Mécanismes de défense; Traitements antirétroviraux; VIHComprehensive approach; Defense mechanisms; Gender; HAART; HIV
NNRTI-based antiretroviral therapy may increase risk of radiation induced side effects in HIV-1-infected patients
Keywords: HIV; HAART; NNRTI; Radiotherapy; Cancer; Radiosensitivity;
Modulation of TIM-3 expression on NK and T cell subsets in HIV immunological non-responders
Keywords: HAART; highly active antiretroviral treatment; HIV; human immunodeficiency virus; INRs; immunological non-responders; IRs; immunological responders; PBMCs; peripheral blood mononuclear cells; TIM-3; T cell immunoglobulin- and mucin-domain-containing molec
High prevalence at computed coronary tomography of non-calcified plaques in asymptomatic HIV patients treated with HAART: A meta-analysis
Keywords: HIV; Non calcific plaques; HAART; CCT;
Telaprevir-based therapy for treatment of HIV-1 and hepatitis C virus co-infected patients: An early access programme
Keywords: Hepatitis C; Telaprevir; HIV; Coinfection; Cirrhosis; Bridging fibrosis; DAA; direct acting antivirals; HAART; highly active anti-retroviral therapy; HCV; hepatitis C virus; HIV; human immunodeficiency virus; PEG-IFN; peginterferon;
Research ArticlePegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study
Keywords: AIDS; acquired immunodeficiency syndrome; HAART; highly active antiretroviral therapy; CI; confidence interval; FIPSE; Spanish Foundation for the Investigation and Prevention of AIDS; GESIDA; Spanish Group for the Study of AIDS; HBV; hepatitis B virus; HC
Research ArticleTrends in mortality after diagnosis of hepatitis C virus infection: An international comparison and implications for monitoring the population impact of treatment
Keywords: HCV; hepatitis C virus; NSW; New South Wales; BC; British Columbia; SVR; sustained virological response; DAAs; direct-acting antiviral agents; HAART; highly active anti-retroviral therapy; HPS; Health Protection Scotland; NRS; National Records of Scotland
Hyperglycemia  enhances kidney cell injury in HIVAN through down-regulation of vitamin D receptors
Keywords: BUN; Blood urea nitrogen; VDR; Vitamin D receptor; HIVAN; HIV-associated nephropathy; DN; Diabetic nephropathy; 8-OHdG; 8-hydroxydeoxyguanosine; HAART; Highly active anti-retroviral therapy; DHE; Dihydroethidium; FSGS; Focal segmental glomerulosclerosis;
Stochastic modelling of viral blips in HIV-1-infected patients: Effects of inhomogeneous density fluctuations
Keywords: Latent infection; HAART; Viral persistence; Viral replication; Laboratory procedures;
Synthesis and biological evaluation of pyridinone analogues as novel potent HIV-1 NNRTIs
Keywords: HIV; human immunodeficiency virus; NNRTIs; non-nucleoside reverse transcriptase inhibitors; SARs; structure and activity relationships; HAART; highly active antiretroviral therapy; RT; reverse transcriptase; NVP; nevirapine; DLV; delavirdine; EFV; efavire
Polymorphisms in DNA polymerase γ affect the mtDNA stability and the NRTI-induced mitochondrial toxicity in Saccharomyces cerevisiae
Keywords: d4T; 3â²-deoxy-2â²,3â²-didehydrothymidine or stavudine; ddC; 2â²,3â²-dideoxycytidine or zalcitabine; Ed4T; 2â²,3â²-didehydro-3â²-deoxy-4â²-ethynylthymidine; EryR; resistant to erythromycin; exo; exonuclease; FLT; 3â²-fluoro-3â²-deoxythymidine;
Leptin in congenital and HIV-associated lipodystrophy
Keywords: POMC; pro-opiomelanocortin; NPY; neuropeptide Y; MRI; magnetic resonance imaging; AMPK; adenosine monophosphate-activated protein kinase; HIV; Human Immunodeficiency Virus; HALS; HIV-associated lipodystrophy syndrome; CT; computed tomography; DEXA; dual-e
A systematic review of filler agents for aesthetic treatment of HIV facial lipoatrophy (FLA)
Keywords: facial volume loss; filler agent; highly active antiretroviral therapy; HIV facial lipoatrophy; HIV lipodystrophy; quality of life; AFT; autologous fat transfer; CaHA; calcium hydroxylapatite; FDA; Food and Drug Administration; FLA; facial lipoatrophy; GO
Treatment outcome of HAART-treated patients in a resource-limited setting: The Belgrade Cohort Study
Keywords: HIV; HAART; Survival; Resource limited settings
Osteonecrosis with renal damage in HIV patients undergoing HAART
Keywords: HIV; AIDS; HAART; Uric acid; Cystatin CHIV, Human immunodeficiency virus; AIDS, Acquired immune deficiency syndrome; HAART, Highly active antiretroviral therapy; TGL, Triglyceride; CHOD PAP, Cholesterol oxidase/para amino phenazone; GFR, Glomerular filtra
Development of a cost-effective assay for genotyping of HIV-1 non-B subtype for drug resistance
Keywords: HAART; Highly Active Antiretroviral Therapy; NRTIs; Nucleoside/Nucleotide Reverse Transcriptase Inhibitors; NNRTIs; Non-Nucleoside Reverse Transcriptase Inhibitors; Genotype; Drug resistance; HIV-1;